Lindbrook Capital’s Portola Pharmaceuticals, Inc. PTLA Stock Holding History

Lindbrook Capital’s Portfolio PTLA Stock Details PTLA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-90	Closed	-$2K	–	1915
2020 Q2	$2K	Hold	90	–	–	﹤0.01%	1486
2020 Q1	$1K	Hold	90	–	–	﹤0.01%	1656
2019 Q4	$2K	Hold	90	–	–	﹤0.01%	1347
2019 Q3	$2K	Hold	90	–	–	﹤0.01%	1325
2019 Q2	$2K	Hold	90	–	–	﹤0.01%	1285
2019 Q1	$3K	Hold	90	–	–	﹤0.01%	1196
2018 Q4	$1K	Buy	+90	New	+$1.85K	﹤0.01%	1329

Lindbrook Capital's PTLA Position: Q3 2020 in Review

Lindbrook Capital sold out of Portola Pharmaceuticals, Inc. (PTLA) in Q3 2020, closing a stake of 90 shares — an estimated $2K sold.

Lindbrook Capital first reported a position in PTLA in Q4 2018 and held it in 7 quarters. The position peaked at $3K in Q1 2019. 0 funds tracked by Wall St. Rank hold PTLA as of Q3 2020.

Lindbrook Capital reported no remaining Portola Pharmaceuticals, Inc. position as of Q3 2020 after selling out during the quarter.
Lindbrook Capital sold 90 Portola Pharmaceuticals, Inc. shares in Q3 2020, an estimated $2K.
Lindbrook Capital first reported a position in Portola Pharmaceuticals, Inc. in Q4 2018 and held it in 7 quarters.
Lindbrook Capital's Portola Pharmaceuticals, Inc. position peaked at $3K in Q1 2019.
0 funds tracked by Wall St. Rank held Portola Pharmaceuticals, Inc. as of Q3 2020.

Based on Lindbrook Capital's 13F filing for Q3 2020, filed 3 Nov 2020.